NEW YORK (GenomeWeb) – Shares of Genomic Health and Pacific Biosciences jumped significantly in November to lead a surge in stock prices for many firms in the omics tools and molecular diagnostics industries.

Overall, the GenomeWeb Index, which tracks the share prices of 31 tools and MDx firms, jumped nearly 7 percent in the month of November. The index far outpaced the performance of the Dow Jones Industrial Average (up .3 percent), the Nasdaq (up 1 percent), and the Nasdaq Biotech Index (up nearly 3 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.